Location: Greenwich, CT
CIK: 0001281446 · Show all filings
Period: Q3 2021 (← Previous) (Next →)
Filing Date: Nov 15, 2021
Total Value: $429M (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| EXEL | EXELIXIS INC | 1,525,000 | $32.24M | 7.5% | $21.82 | -14.9% | COM | 30161Q104 |
| — | ARENA PHARMACEUTICALS INC | 530,670 | $31.6M | 7.4% | $60.39 | — | COM NEW | 040047607 |
| — | KADMON HLDGS INC | 3,375,000 | $29.4M | 6.8% | $4.16 | — | COM | 48283N106 |
| BCAB | BIOATLA INC | 844,002 | $24.85M | 5.8% | $38.96 | 0.0% | COM | 09077B104 |
| RCKT | ROCKET PHARMACEUTICALS INC | 765,000 | $22.87M | 5.3% | $38.30 | -5.0% | COM | 77313F106 |
| MGNX | MACROGENICS INC | 1,000,000 | $20.94M | 4.9% | $18.17 | +32.6% | COM | 556099109 |
| — | DICERNA PHARMACEUTICALS INC | 799,999 | $16.13M | 3.8% | $20.16 | — | COM | 253031108 |
| UTHR | UNITED THERAPEUTICS CORP DEL | 86,667 | $16M | 3.7% | $100.63 | +95.7% | COM | 91307C102 |
| VRTX | VERTEX PHARMACEUTICALS INC | 85,000 | $15.42M | 3.6% | $195.24 | 0.0% | COM | 92532F100 |
| TVTX | TRAVERE THERAPEUTICS INC | 625,000 | $15.16M | 3.5% | $24.05 | -23.6% | COM | 89422G107 |
| ANAB | ANAPTYSBIO INC | 549,545 | $14.9M | 3.5% | $24.35 | +4.2% | COM | 032724106 |
| CYTK | CYTOKINETICS INC | 391,429 | $13.99M | 3.3% | $29.44 | 0.0% | COM NEW | 23282W605 |
| BIIB | BIOGEN INC | 47,500 | $13.44M | 3.1% | $288.02 | +13.8% | COM | 09062X103 |
| URGN | UROGEN PHARMA LTD | 750,000 | $12.62M | 2.9% | $15.85 | 0.0% | COM | M96088105 |
| DYN | DYNE THERAPEUTICS INC | 745,000 | $12.1M | 2.8% | $18.70 | -5.2% | COM | 26818M108 |
| — | SAGE THERAPEUTICS INC | 269,010 | $11.92M | 2.8% | $46.70 | — | COM | 78667J108 |
| XENE | XENON PHARMACEUTICALS INC | 700,000 | $10.7M | 2.5% | $17.38 | 0.0% | COM | 98420N105 |
| — | TRICIDA INC | 1,974,000 | $9.159M | 2.1% | $4.49 | — | COM | 89610F101 |
| PBYI | PUMA BIOTECHNOLOGY INC | 1,300,000 | $9.113M | 2.1% | $10.19 | -26.5% | COM | 74587V107 |
| OLMA | OLEMA PHARMACEUTICALS INC | 329,086 | $9.07M | 2.1% | $28.46 | -5.1% | COM | 68062P106 |
| — | NEKTAR THERAPEUTICS | 504,691 | $9.064M | 2.1% | $17.96 | — | COM | 640268108 |
| ACRS | ACLARIS THERAPEUTICS INC | 500,000 | $9M | 2.1% | $16.03 | 0.0% | COM | 00461U105 |
| RFL | RAFAEL HLDGS INC | 285,714 | $8.78M | 2.0% | $45.91 | 0.0% | COM CL B | 75062E106 |
| — | MAGENTA THERAPEUTICS INC | 1,170,000 | $8.518M | 2.0% | $9.65 | — | COM | 55910K108 |
| CTMX | CYTOMX THERAPEUTICS INC | 1,500,000 | $7.635M | 1.8% | $6.98 | -23.3% | COM | 23284F105 |
| — | RIGEL PHARMACEUTICALS INC | 1,980,000 | $7.187M | 1.7% | $4.17 | — | COM NEW | 766559603 |
| — | AEGLEA BIOTHERAPEUTICS INC | 900,000 | $7.155M | 1.7% | $7.50 | — | COM | 00773J103 |
| PHAT | PHATHOM PHARMACEUTICALS INC | 220,863 | $7.09M | 1.7% | $33.23 | 0.0% | COM | 71722W107 |
| APLS | APELLIS PHARMACEUTICALS INC | 200,000 | $6.592M | 1.5% | — | — | Call | 03753U106 |
| — | KINIKSA PHARMACEUTICALS LTD | 480,000 | $5.467M | 1.3% | $11.39 | — | COM CL A | G5269C101 |
| PCVX | VAXCYTE INC | 98,061 | $2.488M | 0.6% | $24.24 | 0.0% | COM | 92243G108 |
| — | REPARE THERAPEUTICS INC | 93,137 | $2.444M | 0.6% | $31.18 | — | COM | 760273102 |
| COLL | COLLEGIUM PHARMACEUTICAL INC | 121,342 | $2.395M | 0.6% | $21.69 | -0.3% | COM | 19459J104 |
| FOLD | AMICUS THERAPEUTICS INC | 249,000 | $2.378M | 0.6% | $9.76 | +4.8% | COM | 03152W109 |
| IFRX | INFLARX NV | 551,918 | $1.429M | 0.3% | $5.12 | -48.6% | COM | N44821101 |
| PRQR | PROQR THRAPEUTICS N V | 30,336 | $254K | 0.1% | $6.53 | 0.0% | SHS EURO | N71542109 |